1 / 12

ART

Activation of the CREB-dependent pathway distinguishes M.tuberculosis -mediated unmasking immune reconstitution syndrome (IRIS) from chronic HIV and HIV-MTB. Dawany N., Kossenkov A., Chang C., Conradie F., Ive , P. Sanne I., Montaner L.J., Showe L., Azzoni L. Study design.

esben
Download Presentation

ART

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Activation of the CREB-dependent pathway distinguishes M.tuberculosis-mediated unmasking immune reconstitution syndrome (IRIS) from chronic HIV and HIV-MTB. Dawany N., Kossenkov A., Chang C., Conradie F., Ive, P. Sanne I., Montaner L.J., Showe L., Azzoni L.

  2. Study design Blood draw u-IRIS RIPE (2 mo) IE (4 mo) Unmasking TB-IRIS ART 1-3 months Blood draw ART Control Group 1: no MTB ART 1-3 months Blood draw ART + RIPE Control group 2: MTB RIPE (1-2 mo) IE (4 mo) ART 1-3 months

  3. Study participant characteristics Unmasking MTB IRIS diagnostic criteria: ACTG Enrollment: • ARV regimen: 106 of 112 subjects: D4t + 3Tc + EFV, median time 45 days (IQR= [28-61]. 2 IRIS exceptions, ART = 111 and 140 days) • No significant differences in: • ART duration and regimen • Baseline CD4 count and VL • Pre-ART CD4

  4. CREB-regulated cytokines and acute-phase reactants in unmasking M. tuberculosis-associated IRIS IL-6 C-reactive protein 25 20 15 pg/ml ng/ml x 10-3 10 5 0 HGF EGF Β2-μglobulin pg/ml pg/ml pg/ml IL-8 Benjamini Hochberg FDR < 0.10 pg/ml

  5. Hypothesis for unmasking MTB-IRIS pathogenesis Inflammatory response Adaptive effectors (e.g. TCR) Pro-inflammatory genes Aspirin • NF-kB NSAID COX-2 inhibitors GSK3 PI3K, Akt MAPK Innate effectors Cellular receptors ( e .g.: TLR, Mannose receptors, DC-SIGN, others) M. tuberculosis HIV-1 Other pathogens? MyD88

  6. Gene expression patterns highlights Threshold= 1.3 fold background expression; ANOVA p value cutoff= 0.05 unmasking MTB IRIS u-IRIS Pattern 1 (total n= 80): Caspase 6, PKA1*, CD226, Heat Shock Protein B1, cMER HIV TB HIV TB u-IRIS Pattern 2 (total n= 61): CDK7, BCL-10, MAPK-7, ERB-B2 TB u-IRIS • Pattern 3 (total n=122): Adenylatecyclase 3*, prostaglanin E synthase, TNF superfamily, E2F4 HIV MTB (independent of IRIS) HIV TB u-IRIS Pattern 4 (total n= 157): CXCR4, IL-16, CD44, CD160, MAPK9 *Upstream of CREB IL-16: A, Baier M, Serfling E, Kurth R. Proc NatlAcadSci U S A. 1999 Feb 16;96(4):1541-6. CXCR4: Cristillo AD, Highbarger HC, Dewar RL, Dimitrov DS, Golding H, Bierer BE. FASEB J. 2002 Mar;16(3):354-64. HSP: Billack B, Heck DE, Mariano TM, Gardner CR, Sur R, Laskin DL, Laskin JD. Am J Physiol Cell Physiol. 2002 Oct;283(4):C1267-77. CD44: Rothman BL, Kennure N, Kelley KA, Katz M, Aune TM. J Immunol. 1993 Dec 1;151(11):6036-42. TNF: Matt T. Acta Med Austriaca. 2002;29(3):77-9.; Spriggs DR, Deutsch S, Kufe DW, Immunol Ser. 1992;56:3-34.. *Downstream of CREB

  7. CREB family gene expression: heat map

  8. CREB family gene expression summary * * * * Kruskall Wallis FDR < 0.10 Wilcoxon < 0.05 Wilcoxon < 0.10

  9. TLR family gene expression: heat map

  10. TLR family gene expression summary * * * Kruskall Wallis FDR < 0.10 Wilcoxon < 0.05 Wilcoxon < 0.10

  11. Conclusions • Unmasking MTB-IRIS is characterized by: • Increased expression of cytokines and acute-phase reactants regulated by the cAMP/CREB pathway • Increased gene expression of CREBL2>CREB5 (transcription activators) • Decreased gene expression of CREBZF (transcription repressor) • These result support a role for an activation of the CREB pathway(s) in the pathogenesis of IRIS • Differential expression of TLR genes (e.g. increased TLR5) suggests another potential activation pathway. • Limitations • Small number of subjects • Lack of CREB and TLR protein expression and activation assessments • Lack of a comparative paradoxical MTB IRIS group • Possible confounding effect of treatment in the MTB control group • Planned studies • Validation of gene array results in larger longitudinal cohorts • Assessment of CREB and TLR protein levels and activity

  12. Acknowledgements • Clinical HIV Research Unit, Department of Medicine, University of the Witwatersrand/ThembaLethu Clinic, Johannesburg, South Africa: • Study participants • Katerina Roussos • Prudence Ive • Francesca Conradie • Ian Sanne • Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa: • Denise Lawrie • Deborah Glencross • Wendy Stevens • Funding: • NIH/NIAID grant RO1 AI069996 to L.A. • The Philadelphia Foundation The Stengel-Miller family • AIDS funds from the Commonwealth of Pennsylvania and from the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health • Cancer Center Grant (P30 CA10815) • Penn Center for AIDS Research (CFAR). • The Wistar Institute, Philadelphia, PA, USA: • NoorDawany • Andrew Kossenkov • Celia Chang • Louise Showe • Luis J. Montaner

More Related